132 related articles for article (PubMed ID: 37819973)
1. Hepatitis D Virus Infection.
N Engl J Med; 2023 Oct; 389(15):1444. PubMed ID: 37819973
[No Abstract] [Full Text] [Related]
2. Seroprevalence and clinical outcome of hepatitis D infection in Qatar.
Abdallah T; Ibrahim T; Hajmusa M; Abdulgayoom M; Elhassan A; Abusabeib A; Babikir M; Abdelrahim S; Daghfal J; Derbala M
East Mediterr Health J; 2022 Nov; 28(11):840-846. PubMed ID: 36515449
[TBL] [Abstract][Full Text] [Related]
3. Prevelance of hepatitis D co-enfection in children with hepatitis B infection: cross-sectional analyses from Western Turkey.
Özgenç F; Ecevit ÇÖ; Erdemir G; Sertöz R; Yağcı RV
Turk J Gastroenterol; 2013; 24(4):345-8. PubMed ID: 24254267
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis D virus infection.
Poss JE
Nurse Pract; 1989 Aug; 14(8):12, 14-5, 18. PubMed ID: 2671823
[TBL] [Abstract][Full Text] [Related]
5. The natural history of hepatitis D virus infection in Illinois state facilities for the developmentally disabled.
Abiad H; Ramani R; Currie JB; Hershow RC
Am J Gastroenterol; 2001 Feb; 96(2):534-40. PubMed ID: 11232702
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iran.
Ghadir MR; Belbasi M; Heidari A; Sarkeshikian SS; Kabiri A; Ghanooni AH; Iranikhah A; Vaez-Javadi M; Alavian SM
Hepat Mon; 2012 Mar; 12(3):205-8. PubMed ID: 22550529
[TBL] [Abstract][Full Text] [Related]
7. Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
Lempp FA; Volz T; Cameroni E; Benigni F; Zhou J; Rosen LE; Noack J; Zatta F; Kaiser H; Bianchi S; Lombardo G; Jaconi S; Vincenzetti L; Imam H; Soriaga LB; Passini N; Belnap DM; Schulze A; Lütgehetmann M; Telenti A; Cathcart AL; Snell G; Purcell LA; Hebner CM; Urban S; Dandri M; Corti D; Schmid MA
J Hepatol; 2023 Nov; 79(5):1129-1138. PubMed ID: 37459920
[TBL] [Abstract][Full Text] [Related]
8. The epidemiological characterization and geographic distribution of hepatitis D virus infection in Libya.
Daw MA; Daw AM; Sifennasr NEM; Draha A; Daw A; Daw A; Ahmed M; Mokhtar E; El-Bouzedi A; Daw I; Adam S; Warrag S
Pan Afr Med J; 2020; 35():120. PubMed ID: 32637018
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatitis B virus genotype D & its mutants in occult hepatitis B infection.
Sengupta S; Panda SK; Acharya SK; Durgapal H
Indian J Med Res; 2013 Sep; 138(3):329-39. PubMed ID: 24135177
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology and clinical outcome of hepatitis D virus (delta) infection in Jordan.
Toukan AU; Abu-el-Rub OA; Abu-Laban SA; Tarawneh MS; Kamal MF; Hadler SC; Krawczynski K; Margolis HS; Maynard JE
Hepatology; 1987; 7(6):1340-5. PubMed ID: 2824316
[TBL] [Abstract][Full Text] [Related]
11. What is the real prevalence of the D virus infection in chronic hepatitis and liver cirrhosis in Romania?
Grigorescu M; Pascu O; Acalovschi M; Radu C
Rom J Gastroenterol; 2003 Sep; 12(3):179-82. PubMed ID: 14502316
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis D virus RNA in acute delta infection: serological profile and correlation with other markers of hepatitis D virus infection.
Buti M; Esteban R; Roggendorf M; Fernandez J; Jardi R; Rashofer R; Allende H; Genesca J; Esteban JI; Guardia J
Hepatology; 1988; 8(5):1125-9. PubMed ID: 3417234
[TBL] [Abstract][Full Text] [Related]
13. Sexual transmission of hepatitis D virus infection in Taiwan.
Wu JC; Lee SD; Govindarajan S; Lin HC; Chou P; Wang YJ; Lee SY; Tsai YT; Lo KJ; Ting LP
Hepatology; 1990 Jun; 11(6):1057-61. PubMed ID: 2365283
[TBL] [Abstract][Full Text] [Related]
14. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.
Buti M; Esteban R; Español MT; Malagelada A; Jardi R; Rodriguez-Frias F; Roget M; Guardia J
J Infect Dis; 1991 Jun; 163(6):1351-3. PubMed ID: 1674749
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.
Zhang Z; Filzmayer C; Ni Y; Sültmann H; Mutz P; Hiet MS; Vondran FWR; Bartenschlager R; Urban S
J Hepatol; 2018 Jul; 69(1):25-35. PubMed ID: 29524530
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.
Değertekin H; Yalçin K; Yakut M
Turk J Gastroenterol; 2006 Mar; 17(1):25-34. PubMed ID: 16830274
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
[TBL] [Abstract][Full Text] [Related]
18. Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus.
Tappero G; Natoli G; Anfossi G; Rosina F; Negro F; Smedile A; Bonino F; Angeli A; Purcell RH; Rizzetto M
Hepatology; 1994 Nov; 20(5):1109-14. PubMed ID: 7523269
[TBL] [Abstract][Full Text] [Related]
19. Correlation of IgM anti-hepatitis D virus (HDV) to HDV RNA in sera of chronic HDV.
Govindarajan S; Gupta S; Valinluck B; Redeker AG
Hepatology; 1989 Jul; 10(1):34-5. PubMed ID: 2737601
[TBL] [Abstract][Full Text] [Related]
20. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.
Wagner N; Rotthauwe HW; Becker M; Dienes HP; Mertens T; Födisch HJ; Brackmann HH
Eur J Pediatr; 1992 Feb; 151(2):90-4. PubMed ID: 1537369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
